Insider Trading Activity For BioRestorative Therapies (OTCMKTS:BRTX)
Robert B Catell , Director of BioRestorative Therapies (OTCMKTS:BRTX) reportedly Bought 5,000 shares of the company’s stock at an average price of 2.8 for a total transaction amount of $14,000.00 SEC Form
Insider Trading History For BioRestorative Therapies (OTCMKTS:BRTX)
On 6/30/2014 Joseph B Swiader, Director, bought 100,000 with an average share price of $0.25 per share and the total transaction amounting to $25,000.00.
On 5/8/2015 Charles S Ryan, Director, bought 200,000 with an average share price of $0.25 per share and the total transaction amounting to $50,000.00.
On 3/1/2016 Robert B Catell, Director, bought 37,500 with an average share price of $4.00 per share and the total transaction amounting to $150,000.00.
On 3/18/2016 John M Desmarais, Director, bought 250,000 with an average share price of $4.00 per share and the total transaction amounting to $1,000,000.00.
On 5/18/2016 Robert B Catell, Director, bought 12,500 with an average share price of $4.00 per share and the total transaction amounting to $50,000.00.
On 9/26/2016 John M Desmarais, Director, bought 80,000 with an average share price of $3.00 per share and the total transaction amounting to $240,000.00.
On 5/9/2018 Robert B Catell, Director, bought 5,000 with an average share price of $2.80 per share and the total transaction amounting to $14,000.00.
Recent Trading Activity for BioRestorative Therapies (OTCMKTS:BRTX)
Shares of BioRestorative Therapies closed the previous trading session at 2.72 down -0.03 0.91% with 0.0 shares trading hands.